Plain-English translation of NCT07421076 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the Advisor HD Grid X Mapping Catheter with the EnSite X EP System, new tools that help doctors create detailed maps of your heart's electrical activity during treatment for paroxysmal atrial fibrillation. Paroxysmal atrial fibrillation is a condition where your heart occasionally beats irregularly, and doctors can treat it using a procedure called ablation. This study wants to confirm that these new mapping tools are safe and work well to help doctors see your heart more clearly during the procedure.
Current mapping technology has limitations, and doctors need better ways to visualize the heart's electrical signals to treat irregular heartbeat more effectively and safely. This trial is testing whether the new treatment can create more accurate heart maps and help improve patient outcomes.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will come to the hospital for your scheduled heart ablation procedure, during which doctors will use the new Advisor HD Grid X Mapping Catheter and EnSite X system to map your heart and perform the treatment. You'll have pre-procedure testing to make sure you're ready, and then you'll undergo the mapping and ablation procedure itself. After the procedure, you'll have follow-up visits and tests to monitor your recovery and how well the treatment worked.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
China